63 - A Day With the Antimicrobial Stewardship Pager

Monday, October 20, 2025

1:45 PM - 3:00 PM US ET

Location: B405-B407

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Interactive Moderator(s)

Lisa Dumkow, Pharm D., BCIDP (she/her/hers)

Antimicrobial Stewardship Clinical Pharmacist
Trinity Health Grand Rapids
Grand Rapids, MI, United States

Slides
RS

Rebecca Same, MD (she/her/hers)

Assistant Professor of Clinical Pediatrics
Children's Hospital of Philadelphia
Philadelphia, PA, United States

Panelist(s)

Christine Lockowitz, PharmD, BCIDP (she/her/hers)

Pediatric Infectious Diseases Clinical Pharmacy Specialist
Department of Pharmacy
St. Louis Children's Hospital
St. Louis, MO, United States
Kevin Schwartz, MD, MSc, FRCPC

Physician
Unity Health Toronto
Toronto, ON, Canada
ES

Erica Stohs, MD MPH (she/her/hers)

Associate Professor
Creighton University Medical Center
Omaha, NE, United States
Nicholas Torney, PharmD, BCIDP

Infectious Diseases/Antimicrobial Stewardship Pharmacist
Munson Medical Center
Traverse City, MI, United States

Disclosure(s):

Lisa E. Dumkow, Pharm D., BCIDP: No financial relationships to disclose.

Rebecca Same, MD: No financial relationships to disclose.

Christine Lockowitz, PharmD, BCIDP: AbbVie Inc: Grant/Research Support; Premier, Inc.: Honoraria; Shionogi, Inc.: Advisor/Consultant

Kevin Schwartz, MD, MSc, FRCPC: No financial relationships to disclose.

Erica Stohs, MD MPH: bioMerieux Inc.: Grant/Research Support; Merck and Company, Inc.: Grant/Research Support

Nicholas Torney, PharmD, BCIDP: No financial relationships to disclose.

Learning Objectives:

At the conclusion of this session, participants will be able to:

Identify effective approaches to limit the overuse of antimicrobials
Determine effective approaches to building a collaborative stewardship environment
Discuss methods to implement antimicrobial stewardship interventions and measure their impact on patient outcomes